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Introduction
Poor sleep quality is highly prevalent in patients with 
lower back pain (LBP) and is associated with high levels 
of pain, psychological distress, and physical disability 1. 
Lumbar radicular pain (LRP) is caused by irritation, in-
flammation, pressure or injury of the lumbar segment 
spinal nerves. The pain propagates along the lower ex-
tremity on the same side as spinal nerve injury and has 
the characteristic of a sharp, piercing sensation or electric 
shock. By definition, radicular pain affects the area out-
side the spine. Patients with lower back pain may experi-
ence pain in the vertebra and along the lower extremities, 
but pain along the legs is more intense in patients with 
LRP. Several recent studies have concluded that epidural 
application of steroids is an effective method for pain treat-
ment in patients with acute lumbar radiculopathy2. Pa-
tients requiring such treatment usually have an inade-
quate analgesia after performing physical therapy and 
other forms of rehabilitation3. Data on the epidural applica-
tion of steroids in most studies include a classical inter-
laminar approach4. By contrast, the pathology of the nerve 
root and the intervertebral disc is located in the anterior 
epidural space. The transforaminal approach for epidural 
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A B S T R A C T
Chronic lumbar radicular pain is connected with the anxiety, depression and sleep disorders. The aims of this study 
are to compare the effect of pain on sleep quality, anxiety and depression in patients receiving interlaminar and transfo-
raminal epidural steroids injections. The study is an original scientific-research work, a prospective randomized controlled 
clinical trial that included 70 patients with lumbar radicular pain at the Clinical Hospital Centre Osijek. The selected 
patients were divided into two groups considering the approach of administration of epidural steroids, the interlaminar 
(IL) and transforaminal group (TF). The anxiety, depression and sleep disorders were evaluated with questionnaires “Hos-
pital Anxiety and Depression Scale (HADS)” and “Questions for assessing sleep in chronic pain”.  In the end 64 patients 
completed the study, 41 women (64.1%) and 23 men (35.9%). Significantly lower values were recorded during the assessment 
of the sleep quality in the group with the interlaminar injection of steroids (ANOVA, p = 0.030), compared to the group with 
the transforaminal injection of steroids (ANOVA, p = 0.002), but there is no difference between the groups. In both groups, 
there is an improvement in anxiety and depression, but only in the sixth measurement a significantly lower evaluation 
value of the HADS questionnaire was obtained in transforaminal (TF) group  (Mann Whitney test, p = 0.025). Within the 
TF group, the values of anxiety (Friedman’s test, p <0.001) and depression (Friedman’s test, p = 0.007) are significantly 
reduced. In patients who received epidural steroids injection with a transforaminal approach, lower levels of depression 
and anxiety were observed as there was a greater reduction in pain, compared to an interlaminar group. Sleep quality was 
higher in patients who received steroids via transforaminal compared to the interlaminar approach.
Keywords: Lumbar radicular pain, epidural steroids injections, interlaminar approach, transforaminal approach, 
anxiety, depression, sleep quality
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steroids injection results in the disposal of steroids in the 
anterior epidural space, very close to the pathology site and 
therefore a lower dose of steroid is required4,5. Although 
the prevailing view is that epidural application of steroid 
is not effective in treating chronic LRP, clinical practice 
denies it every day. By duration, pain can be acute and 
chronic. Chronic pain has no protective role; it is long last-
ing, exhausting and becomes a chronic pain syndrome. 
Chronic pain is a personal experience, accompanied by a 
series of psychological and emotional reactions that sig-
nificantly change the quality of the patient’s life. Pain has 
a direct effect on sleep quality, and numerous studies have 
shown that pain has a significant impact on the develop-
ment of anxiety and depression.
Hypothesis and aim of the study
Previous studies have shown the efficacy of epidural 
application of steroids in the treatment of the acute, but 
also and chronic radicular pain. The transforaminal ap-
proach for epidural steroids injections has yielded better 
results, although numerous studies have proven success-
ful pain reduction by the interlaminar approach.
It is well known that pain is a direct trigger for anxiety 
and depression, as well for sleep disorders. After all the 
above we can make a hypothesis that epidural applications 
of steroids with an interlaminar or transforaminal ap-
proach will decrease the intensity of pain, which will re-
sult in a decreasing degree of anxiety and depression and 
improving the quality of sleep for the patients with chron-
ic lumbosacral radicular pain. 
Aims of this study:
1.  Compare the effect of pain on sleep quality in pa-
tients receiving interlaminar and transforaminal 
steroid injections in chronic lumbar radicular pain
2.  Compare the effect of pain on anxiety and depression 
in patients receiving interlaminar and transforami-
nal steroid injections in chronic lumbar radicular 
pain
Materials and methods
The study was carried out as an original scientific re-
search work, as a prospective randomized controlled clin-
ical trial. The Ethics Committee of the Osijek Clinical 
Hospital Center and the Faculty of Medicine at the Josip 
Juraj Strossmayer University in Osijek approved research 
conducting. Patients with radicular pain were selected in 
the Pain Clinic, Department of Anesthesiology and Inten-
sive Care of the Clinical Hospital Center Osijek. Selected 
patients were divided into two groups considering the ap-
proach of administration of epidural steroids, the inter-
laminar (IL) and transforaminal group (TF).
The selection was made by random selection, “pulling 
out of the hat”. Basal evaluation has been done just before 
randomization and the first epidural steroid injection 
(ESI). The first checkup was done just before the second 
epidural steroid injection, the second checkup was per-
formed before the third epidural steroids injection. The 
third checkup has been performed two weeks after the 
third epidural steroids injection. The fourth and fifth 
checkup was performed after 12 and 24 weeks after the 
first basal assessment. Randomization was continued un-
til a total of 64 patients, or respectively 32 patients per 
each group, did not complete the tracking via all six visits 
to the doctor in both groups. Patients who have fallen out 
from monitoring for any reason are not involved in data 
processing. All patients had magnetic resonance imaging 
(MR) of the lumbosacral segment of the spine and electro-
myoneurography of lower extremities (EMNG). ESI was 
performed at the level of the spine with overlapping of MR 
and EMNG verified pathology site and the patient radicu-
lar pain dermal distribution. In cases with several patho-
logical levels as a possible cause of radicular pain, ESI has 
been applied at the level that has been most pathologi-
cally altered (EMNG and MR verified).
To include patients in the study, they had to meet the 
inclusive criteria:
• Age between 18 and 80 years 
•  The intensity of pain along the leg assessed by a vi-
sual-analog scale (VAS 0-10) equal to or greater than 
five before the first epidural steroids injection
•  The intensity of pain along the leg stronger than the 
lower back pain
•  Patients with lumbar radicular pain that in the last 
6 months did not have a satisfactory response to con-
ventional treatment (pharmacotherapy and physical 
therapy)
•  Spinal stenosis or compression of the lateral lumbar 
stenosis duct documented by MR images, which 
could potentially explain the clinical patient’s signs 
and symptoms of radicular pain
•  The absence of significant motor deficiency or fecal/
urine incontinence
Excluding criteria, for patients were the same for both 
groups (they have not been included or they have been 
excluded from the study if they have one exclusion crite-
ria): 
• Age younger than 18 years or older than 80 years 
•  The intensity of pain along the leg assessed by a vi-
sual-analog scale (VAS 0-10) equal or less than four 
•  The intensity of the low back pain stronger than pain 
along the leg
•  Symptoms of lumbar radicular pain shorter than 6 
months
•  Pregnant and lactating women or women in the gen-
erative age without adequate contraception
• Patients with bilateral radicular pain
• Patients with progressive neurological deficit
• Patients with previous lumbar spine surgery
•  Patients with coagulation disorder, including those 
receiving anticoagulant medications
•  Patients with previous allergic reactions to local an-
esthetics, steroids, contrasts or opiates
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•  Patients who received epidural steroids injection in 
a period of a year ago
•  Patients with a history of addiction to opioids or pa-
tients currently on long-acting opioids
After careful selection of patients who met the inclu-
sion criteria of the study, an interview was conducted with 
patients, in which the researcher explained to them the 
nature, the course, treatment options, the possible risks 
of the treatment, the goal of the treatment, and the pos-
sible outcome of the treatment of their lumbar radicular 
pain. After agreeing to participate in the research, the 
patients signed an informed consent for performing the 
procedure and consent for the collecting and statically 
processing of data for scientific purposes, with the protec-
tion of patients identity. All collected materials were en-
crypted for the anonymity of patients.
Patients who entered the study were not subjected to 
aggressive tests or therapeutic interventions outside of the 
usual procedures for treating such patients.
After signing informed consent, the patients filled the 
questionnaire for receiving basic information about the 
patient. This questionnaire represents a patient’s history 
and patients completed it before the first injection of ste-
roids. During controls, patients only filled new changes. 
Patients also completed questionnaires assessing the ef-
fect of pain on sleep quality, anxiety, and depression. 
These questionnaires are:
• Questions for assessing sleep in chronic pain
• Hospital Anxiety and Depression Scale (HADS)
By reading a scale (0 to 100) about sleep estimation in 
chronic pain, higher values  indicated better sleep quality, 
and lower values  indicated poor sleep quality. HADS is a 
questionnaire consisting of 14 questions - seven related to 
depression and seven to anxiety. Four responses are pos-
sible, and the scoring scale is ranging from 0 to 3. The 
total points for each part are from 0 to 21. It is assumed 
that the normal state is 0 to 7 points, the border disease 
state is from 8 to 10 points, and a disease state is from 11 
to 21 points. Patients received a series of three steroid in-
jections into the lumbar epidural space by the interlaminar 
or transforaminal approach, within 2 weeks intervals. Pa-
tients did not receive anticonvulsive or antidepressive 
therapy during follow-up. For mitigation of penetrating 
pain, patients received one or two Tramadol 50 mg pills as 
needed (max. 400 mg / 24 hours). Researchers monitored 
and reevaluated patients on each visit before ESI applica-
tion, and three and six months after first steroid injection. 
Patients reported adverse reactions on each control, which 
was recorded in a special paper form for each patient.
Statistics
Numerical data are described by the basic measures of 
medium and dispersion. The normality of distribution of 
observed numeric variables was tested by Kolmogorov-
Smirnov test. The category variables are described in ab-
solute and relative frequencies. Testing of differences was 
done for groups of respondents in six measurements. To 
study the differences between the two independent groups 
within each measurement, Student’s T-test and Mann-
Whitney test were used, depending on the normality of the 
distribution. The differences between categorical vari-
ables were tested by the χ2 test (Fisher’s exact test). To 
investigate the differences between the six measurements 
of individual parameters, ANOVA was used for repeated 
measurements and Friedman’s test, a nonparametric test 
of variance analysis for dependent measurements. We 
used originally written database programs and statistical 
package Stat Soft, Inc. (2005). Statistica (data analysis 
software system), version 7.1. www.statsoft.com.
To evaluate the importance of the results obtained, the 
level of importance α = 0.05 was chosen.
During this clinical research, ethical principles were 
respected in accordance with well-known and established 
fundamental principles of ethics and human rights protec-
tion valid in the field of medical sciences.
Results
In our research, we included 70 patients by random 
selection, and 64 of them completed the study. By gender, 
41 were women (64.1%) and 23 men (35.9%). Six patients 
did not complete the monitoring. Three patients left each 
group after the first, second or third ESI and they did not 
enter in the statistical analysis. Patients in both groups, 
transforaminal and interlaminar, had a significant reduc-
tion in pain intensity after the receiving epidural steroids 
injection procedure during the control visits.6
Significantly lower values were recorded during the 
assessment of the sleep quality in the group with the in-
terlaminar injection of steroids (ANOVA, p = 0.030), com-
pared to the group with the transforaminal injection of 
steroids (ANOVA, p = 0.002), but there is no difference 
between groups (Figure 2). 
Mood disorders (depression, anxiety) were followed 
with the HADS questionnaire in order to obtain the over-
all impression of pain and its impact on the general condi-
tion of the patients. It consists of 14 questions; seven refer 
to depression and seven to anxiety. Four responses are 
possible, and the scoring scale is ranging from 0 to 3. The 
Fig.1. Evaluation of pain intensity after epidural steroid 
administration by transforaminal or interlaminar approach.6
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total points for each part are from 0 to 21. It is assumed 
that the normal state is 0 to 7 points, the border disease 
state is from 8 to 10 points, and a disease state is from 11 
to 21 points. The only psychiatrist sets the final diagnosis 
of the depressive or anxiolytic condition, after completing 
the clinical evaluation. 
In both groups, there is an improvement in anxiety and 
depression, but only in the sixth measurement a signifi-
cantly lower evaluation value of the HADS questionnaire 
was obtained in transforaminal (TF) group  (Mann Whit-
ney test, p = 0.025) (Table 1). Within the TF group, the 
values  of anxiety (Friedman’s test, p <0.001) and depres-
sion (Friedman’s test, p = 0.007) are significantly reduced 
(Table 1, Figure 3 and 4). 
Discussion
In patients with chronic pain, the usual problems are 
insomnia and depression7. A group of authors from Turkey 
compared sleep quality in 200 patients with low back pain 
(LBP) versus 200 healthy individuals. In patients with 
LBP, the mean Pittsburgh Sleep Quality Index (PSQI) 
was 8.1 +/- 4.3 versus 4.6 +/- 3.4 in healthy individuals in 
the control group. (p <0.001). This study showed that sleep 
quality was significantly impaired in patients with LBP 
compared to a healthy control group8. Bahouq et al., in 
their study conducted in 2013, found that the prevalence 
of insomnia in patients with lower back pain was 64%9. 
Before first epidural steroids injection, over 50% of pa-
TABLE 1
AVERAGE VALUES  OF HADS ESTIMATES OF ANXIETY AND DEPRESSION
HADS questionnaire Epidural steroids injection Total p†
Interlaminar Transforaminal
Sv (±SD)* Sv (±SD)* Sv (±SD)*
ANXIETY
measurement 12,03 (3,82) 11,25 (4,4) 11,64 (4,11) 0,531
measurement 11,09 (4,89) 10,28 (4,5) 10,69 (4,7) 0,467
measurement 11,28 (5,46) 9,81 (4,7) 10,55 (5,11) 0,233
measurement 10,47 (5,26) 9,75 (4,4) 10,11 (4,84) 0,666
measurement 10,66 (5,28) 9,22 (4,7) 9,94 (5,01) 0,148
measurement 11 (5,17) 9,09 (4,8) 10,05 (5,04) 0,071
DEPRESSION
measurement 10,63 (3,94) 10,56 (4,37) 10,59 (4,13) 0,930
measurement 10,56 (4,26) 9,69 (4,62) 10,13 (4,43) 0,599
measurement 10,25 (4,11) 9,75 (4,46) 10 (4,27) 0,666
measurement 9,72 (4) 9,03 (4,71) 9,38 (4,35) 0,576
measurement 10,03 (3,95) 8,69 (4,88) 9,36 (4,45) 0,240
measurement 10,44 (3,74) 8,44 (4,93) 9,44 (4,46) 0,025
* Mean value (standard deviation); †Mann-Whitney test
Fig.2. Evaluation of sleep quality in chronic pain by groups and 
measurements.
Fig.3. HADS anxiety assessment by measurements and groups.
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tients in this study had a moderate or strong adverse effect 
of pain on sleep quality. This is not surprising because 
sleep disorders and chronic pain are associated in the way 
that pain leads to sleep disorders, and sleep disorders in-
crease the perception of pain.
A group of German authors made a meta-analysis of 
34 studies. The perception of pain in patients with lower 
back pain is significantly associated with depression and 
fear10. Inadequately diagnosed and insufficiently treated 
sleep disorders, with emotional, cognitive and behavioral 
maladaptive processes in patients with chronic pain, can 
lead to the development of chronic sleep disorders, which 
then contribute to mentioned maladaptive emotional, cog-
nitive and behavioral responses 11. The insomnia  will also 
significantly enhance the impact of pain on daily function-
ing, particularly when it comes in pair with a major de-
pressive disorder7. 
In our study, the patients in both groups in the first 
control had a severe state of anxiety. At the sixth control, 
patients in the IL group on average stayed in an illness 
state of anxiety, and in the TF group, the condition im-
proved so that the patient’s average was in the border state 
of anxiety. In the assessment of depression, both groups 
were in a state of illness, and at the end of monitoring 
after six months, they were in a border state.
A group of authors from Turkeystudied the effect of 
transforaminal use of steroids on functional status, psy-
chological status and sleep quality in patients with a her-
niated disc of the lumbar spine. The results showed an 
83% reduction in pain intensity, a 71% increase in func-
tional status, and a 69% improvement in sleep quality 2 
weeks after the procedure. After 12 months, slight de-
crease in improvement appear, so that the reduction of 
pain intensity at the end was 73%, 65% increase in func-
tional status and improvement in sleep quality by 62%12. 
In our study, in both groups of patients (interlaminar and 
transforaminal ESI), the proportion of patients with anx-
iety (65.6% and 53.1%) is higher than the proportion of 
anxiety in the general population (18%), which is consis-
tent with other studies. Shilabant and al. compared the 
interaction of pain intensities, sleep disorders and emo-
tions in patients with non-specific pain in the lumbar 
spine (NSLBP) in 555 patients and 112 healthy subjects. 
Patients with NSLBP had a greater incidence of sleep dis-
order, anxiety disorders and depression than healthy sub-
jects. More than half of the patients with NSLBP (278-
50.1%) experienced anxiety symptoms, 379 (68.3%) had 
depression, and 161 (29.0%) had a sleep disorder. In a 
group of 112 healthy subjects, 18 (16.1%) had anxiety 
symptoms, 13 (11.6%) had depression and 14 (12.5%) had 
sleep disorders. Patients with NSLBP had statistically 
significantly more symptoms of anxiety, depression and 
sleep disorders (p <0.01)13. Simultaneously with the treat-
ment of pain, it is of great importance to treat anxiety and 
depression due to the strong interaction of pain with anx-
iety and depression, as vice versa. Depression and pain 
significantly affect chronic pain, but also the quality of life 
of patients. Hiyama et al. have studied the effect of depres-
sion and neuropathic pain on the quality of life in patients 
with Low Back Pain (LBP). The incidence of neuropathic 
pain was higher in patients with depression than in pa-
tients who did not have depression. Patients with depres-
sion had a higher intensity of pain (NRS) and poor qual-
ity of life (QQL) 14. 
Among the group of patients suffering from a major 
depression, 69% of them complain of physical symptoms, 
among which the most common are a headache, arthritis, 
chest pain, joint pain, muscle pain, digestive disorders, 
cardiac palpitations, fatigue, fluid interference, and libido 
interference. Non-inclusion of physical symptoms in the 
therapeutic goal is the most common cause of depression 
relapse, and 76% of patients have experienced relapse 
within 10 months15,16. 
In primary health care system patients appear with 
painful physical symptoms (a headache, abdominal pain, 
muscular pain) in 80% of all cases, and pain symptoms 
are clinically significant in 92% of primary depressive 
patients17. Of the total number of patients with severe de-
pression disorder, 65% have painful symptoms, while in 
35% there are no painful symptoms. The success of recog-
nizing depression when only affective symptoms are pres-
ent is 90%, while with the presence and physical symp-
toms success is reduced to 50%18. In the co-morbidity of 
chronic pain (musculoskeletal pain) and depression as well 
as anxiety, disabling effect is higher and the quality of life 
is worse19. Although it is understandable that depression 
and painful conditions occur often together, and their 
treatment is more expensive and harder than each condi-
tion individually, their interaction is incomprehensible. 
Large studies have shown that the symptoms of depres-
sion are the precursor of future episodes of arthritis, neck 
pain and musculoskeletal symptoms compared to those 
patients without depressive symptoms20. Other studies 
have shown that low back pain is twice as likely in de-
pressed individuals as compared to individuals without 
depression21. Patients with multiple painful symptoms 
such as back pain, headache, abdominal pain, chest pain, 
and facial pain have a 3-5 times greater chance of develop-
ing depression than painless patients and painful symp-
toms associated with at least double increase in the risk 
of coexisting depression21. In addition, patients with 
Fig. 4. HADS depression assessment by measurements and 
groups.
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chronic pain have three times higher possibility to meet 
the criteria than those patients who do not have chronic 
pain22.
The relationship between depression and pain becomes 
stronger if the strength of these two conditions increases. 
For example, an increase of pain intensity will increase 
the symptoms of depression and the depression will dete-
riorate. In the same way, if the symptoms of depression 
increase, the patients will more regret on pain, often go to 
the visits to the doctor due to back pain. It will lead to 
greater number of diagnostic procedures, increase in 
medications using, and the cost of such treatment will be 
far greater in comparison with those who do not have de-
pression24,25,26. Depression in patients with lower back pain 
is associated with poor treatment outcomes. Social sup-
port is a factor that can be affected and so mitigate the 
symptoms of depression could improve the outcome of the 
treatment of patients with low back pain. More social sup-
port is associated with a better recovery of symptoms of 
depression. 
It follows that in the treatment of pain in the lumbar 
spine, multidisciplinary approach, which include social 
support to patients, is extremely important27. The pres-
ence of pain negatively affects the recognition and treat-
ment of depression. Depression is often unrecognizable 
and therefore it is not treated. It is not yet quite clear the 
mechanism of why patients with depression and pain have 
a weaker response to the usual treatment of depression in 
comparison with patients suffering from depression with-
out pain. Depression also increases the overall cost of 
health care for patients with pain, lead to a weaker re-
sponse to pain management, decrease patient’s satisfac-
tion and result in more common additional episodes of 
pain in the future28. The combination of depression and 
pain is associated with a worse clinical picture in com-
parison with a present of only one clinical entity. It is vital 
to treat depression and pain at the same time to get opti-
mal treatment outcomes.
Conclusion
In patients who received epidural steroids injection 
with a transforaminal approach, lower levels of depression 
and anxiety were observed as there was a greater reduc-
tion in  chronic pain, compared to an interlaminar group. 
Sleep quality was higher in patients who received steroids 
via transforaminal compared to the interlaminar ap-
proach. 
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UTJECAJ EPIDURALNIH INJEKCIJA STEROIDA S TRANSFORAMINALNIM I INTERLAMINALNIM 
PRISTUPIMA NA KVALITETU SPAVANJA, ANKSIOZNOST I DEPRESIJU KOD PACIJENATA S 
KRONIČNOM LUMBALNOM RADIKULARNOM BOLI
S A Ž E T A K
Bol u lumbalnom dijelu kralježnice je povezana sa anksioznošću, depresijom i poremećajem spavanja. Ciljevi ovoga 
istraživanja su usporediti utjecaj boli kod bolesnika sa boli u lumbalnom dijelu kralježnice na kvalitetu spavanja, te 
anksioznost i depresiju  kod interlaminarne i transforaminalne primjene steroida. Provedena je prospektivna random-
izirana studija u KBC Osijek. U studiju je uključeno 70 bolesnika koji su podjeljeni u dvije grupe slučajnim odabirom 
obzirom na način primjene epiduralnih steroida. Kvaliteta spavanja, anksioznost i depresija su evaluirani »Upitnikom 
za procjenu spavanja kod kronične boli« i »Bolničkom skalom anksioznosti i depresije (HADS)«. Istraživanje je završilo 
64 ispitanika od kojih je 41 bila žena (64.1%) i 23 (35.9%) muškaraca. Značajno su niže vrijednosti u procjeni kvalitete 
spavanja u grupi s interlaminarnim injiciranjem steroida (ANOVA, p=0,030), u odnosu na grupu s transforaminalnim 
injiciranjem steroida (ANOVA, p=0,002), no nema razlike među skupinama. U obje skupine dolazi do poboljšanja po 
pitanju anksioznosti i depresije, no samo su kod šestog mjerenja značajno niže vrijednosti procjene HADS upitnikom kod 
ispitanika iz TF skupine (Mann Whitney test, p=0,025). Unutar TF skupine značajno se smanjuju vrijednosti kod 
anksioznosti (Friedmanov test,p<0,001) i kod depresije (Friedmanov test, p=0,007). Kod bolesnika koji su steroide 
primili transforaminalnim u odnosu na interlaminarni pristup zabilježene su niže razine depresije i anksioznosti jer je 
bilo veće smanjenje boli. Kvaliteta spavanja bila je veća kod bolesnika koji su steroide primili transforaminalnim u od-
nosu na interlaminarni pristup.

